Help us: Donate
Follow us on:
×

Search Results for: Ichor

April 11, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages of aging and may one day lead to a future without the diseases of aging. We were glad to have the opportunity to conduct a...
August 07, 2018
Ichor Therapeutics, a life science company in Lafayette, New York, is one of the big players in the world of rejuvenation biotechnologies. Since its founding in 2013, it has been growing and expanding its portfolio of companies working on therapies against the diseases of aging; on August 1, 2018, Ichor announced the formation of its...
June 01, 2020
May has brought us a lot of interesting advances in the world of rejuvenation, and we at Lifespan.io have moved forward with projects of our own, including our upcoming Ending Age-Related Diseases 2020 conference, an accelerated Journal Club schedule with more speakers, a roundtable discussion, and our new general science series focused on the potential...
January 03, 2020
2019 is quite a milestone for LEAF; this will be our fourth year of bringing you the latest industry news, organizing online events, hosting our annual conference in New York, and crowdsourcing important research projects over at Lifespan.io. We have been incredibly busy and, as has been customary in previous years, we will be taking...
October 01, 2019
With a new month ahead and an old one behind, it's again time to review the latest news and progress in the field of rejuvenation biotechnology. There's a number of past events to look back upon, including Age-Related Diseases 2019, and upcoming ones to look forward to; let's get started. LEAF News Team and activities...
September 25, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Dr. Kelsey Moody gave a detailed presentation on macular degeneration, discussing its origins in the lysosomes and how it progresses...
August 20, 2019
It seems that billionaire biotech investor Jim Mellon is the flavor of the month as he continues the drive to create a rejuvenation biotech industry. Jim and his colleagues at Juvenescence have announced that they have secured another $100M for the company, and it will be used to invest and support the growth of promising...
July 30, 2019
Ending Age-Related Diseases 2019 is over, and the dust is starting to settle after what can only be described as a hugely successful event for our organization. This was our second year of running a conference, and once more, we focused on the research and investment areas of rejuvenation biotechnology. Totally sold out We wish...
July 09, 2019
The Life Extension Advocacy Foundation, a nonprofit organization dedicated to promoting healthy longevity and aging research through crowdfunding and advocacy initiatives, is hosting its second annual scientific conference, Ending Age-Related Diseases: Investment Prospects and Advances in Research, at the Cooper Union in New York City on July 11th-12th. The goal of this conference is to...
July 08, 2019
There are now only two days to go before the Ending Age-Related Diseases 2019 conference at the Cooper Union in New York City. This is our annual conference that brings together industry leaders from biotech research and business. We have almost sold out of tickets, so if you are thinking about attending, you should act...
1 2 3 5
July 27, 2019
BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER July 2019 will see us return to the Frederick P. Rose Auditorium at the Cooper Union in New York City for our second annual conference focusing on aging research, biotech business, and investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and...
May 14, 2019
A BIOTECH IN A BOX WORKSHOP Alongside our Ending Age-related Diseases 2019 annual conference, we are proud to announce the launch of a special pre-conference biotech workshop led by Dr. Kelsey Moody, CEO of Ichor Therapeutics, a successful and rapidly growing rejuvenation biotechnology company. This joint event between the Life Extension Advocacy Foundation and Ichor...
March 23, 2019
You can download a copy of the event abstracts booklet here should you wish to do so. Day 1, Thursday, July 11th 8:00 - 9:00  Registration, Networking 9:00 - 9:10  Welcome talk by LEAF President Keith Comito 9:10 - 9:15  Welcome from Maurice Kanbar Center for Biomedical Engineering Director Oliver Medvedik 9:15 - 9:45 Opening...
November 17, 2018
Celebrating Our Second Conference We brought together leading aging researchers and biotech investors for two action-packed days of science and business. SUPPORTING AGING RESEARCH On July 11th, 2019, we hosted our second conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, part of the Cooper Union campus in...
July 20, 2018
Celebrating Our First Conference We brought together leading aging researchers and biotech investors for an action-packed day of science and business. SUPPORTING AGING RESEARCH On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus...
April 04, 2018
Part of a Great Community We appreciate the dedication of others working in the field, and we are proud to be a part of the community. NON-PROFITS AND GOVERNMENT INSTITUTIONS RELEVANT COMPANIES BLOGS AND WEBSITES  

No Community Members Found.

See Content You May Be Interested In Below

Latest Event

LifeXtenShow

LEAF Activities

Fight Aging!
February 18, 2019
Ichor Therapeutics, led by Kelsey Moody, was one of the first companies to emerge from the core SENS Research Foundation community. The company has grown over the years and is now at the head of a collection of spin-out startups focused on a variety of approaches to aging, such as senolytic therapies to destroy senescent...
Fight Aging!
September 24, 2018
24 Sep 2018 24Sep2018 $1.5 Million Raised for Ichor Therapeutics Portfolio Company Auctus Biologics Loading... Loading... The folk at Ichor Therapeutics are spinning off subsidiary companies at a fair pace, each devoted to either SENS rejuvenation biotechnology or life science infrastructure technologies: LysoClear; Antoxerene; Auctus Biologics; RecombiPure. At this point, the staff at Ichor Therapeutics...
Fight Aging!
April 23, 2018
Ichor Therapeutics is the most mature of the US-based companies that have emerged from the SENS rejuvenation research community in recent years. You might recall a number of interviews back in the Fight Aging! Archives with founder and CEO Kelsey Moody. He has his own take on how our community should proceed from laboratory to...
Fight Aging!
October 20, 2019
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/https://www.fightaging.org/newsletter/Longevity Industry Consulting ServicesReason, the founder...
Fight Aging!
October 14, 2019
Kelsey Moody of Ichor Therapeutics presented on the LysoClear development program at the Ending Age-Related Diseases conference organized by the Life Extension Advocacy Foundation earlier this year. LysoClear is an example of the commercial development of a rejuvenation therapy, taken all the way from the starting point of the discovery of microbial enzymes capable of...
Fight Aging!
April 02, 2019
The Life Extension Advocacy Foundation (LEAF) volunteers were all at the Undoing Aging conference in Berlin this last week. Given that they, like most of the insiders, were spending much of their time interviewing and networking, they are little better a source than I am when it comes to reporting on the actual content of...
Fight Aging!
August 10, 2018
I had promised a short update on progress at Repair Biotechnologies, the company that Bill Cherman and I founded earlier this year to help advance the state of therapies to treat aging, and here it is. We recently closed a seed round with a number of investors in our close-knit community, and are presently setting...
Repair Biotechnologies is Hiring a Senior Research Scientist / Project Lead in New York State to Speed Work on the Treatment of Aging
July 23, 2018
Bill Cherman and I founded Repair Biotechnologies earlier this year in order to work on a few carefully selected approaches to human rejuvenation, following the SENS philosophy of damage repair. If one can be involved in the hands-on work, then why not be involved in addition to cheering from the sidelines? So here we are,...
Juvenescence Announces a Small Molecule Senolytics Joint Venture with Antoxerene
July 16, 2018
The Ichor Therapeutics contingent present at the Ending Age-Related Diseases conference in New York last week were quite pleased that the timing worked out to allow them to announce during the conference a $10 million investment from Juvenescence into a joint venture with their portfolio company Antoxerene. Antoxerene started as a protein biotechnology infrastructure company,...
Fight Aging!
April 29, 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to...